Development partners

Searching for pipeline?

MondoTwin works with pharma, biotech, foundations, investors, and public funders looking for clinical-stage rare-disease programs. We find them in the evidence, construct them to be licensable, and support the transaction. Mandates are scoped individually.

  1. 01

    Programs from our own pipeline, available under confidentiality.

  2. 02

    Targeted searches on mandate, across the world’s clinical evidence and the research hosted on MondoTwin.

  3. 03

    Assets constructed in the partner’s name and supported to signature.

Tell us what you are looking for

Therapeutic area, stage, modality, deal type, geography. A short note is enough; we will come back to you to scope the conversation.

Rare diseases have waited long enough.

Let's build what moves them forward.